Maureen Corrigan, Director, Evidence Based Practice, Professional & Clinical Affairs: “We’re delighted to report that the Endocrine Society is well underway in updating its Clinical Practice Guideline (CPG) on the pharmacological management of obesity. As part of the development process, we recently invited a group of patient partners—people who have experience living with obesity—to share their perspectives, ideas, and values around treatment options.”
A new Endocrine Society guideline on Primary Aldosteronism updates a 2016 guideline, and suggests that everyone who is diagnosed with hypertension have their levels of aldosterone, renin, and potassium checked.
A joint guideline from the Endocrine Society and the European Society of Endocrinology (ESE) recommends women with diabetes receive proper preconception care and access to emerging diabetes technology and therapeutics to manage their blood sugar before, during and after pregnancy.
Maureen Corrigan, Director of Clinical Practice Guidelines and Professional & Clinical Affairs: “One of the most important functions of the Endocrine Society is to develop and maintain an up-to-date portfolio of Clinical Practice Guidelines (CPGs) that provide relevant, timely, evidence-based recommendations for patient care and clinical practice.”
The 2017 Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons is an update to the 2009 version, which establishes and standardizes the terminology and safe treatment of gender dysphoric/gender-incongruent persons and reaffirming the role of endocrinologists.
The 2024 guideline on vitamin D for the prevention of disease updates and replaces the 2011 Evaluation, Treatment, and Prevention of Vitamin D Deficiency guideline and focuses on the use of vitamin D to lower the risk of disease in individuals without established indications for vitamin D treatment or 25(OH)D testing.
We are pleased to announce the first Endocrine Society and European Society of Endocrinology joint clinical practice guideline (CPG), Diagnosis and Therapy of Glucocorticoid-Induced Adrenal Insufficiency. The guideline provides clinicians with practical guidance on the evaluation of adrenal function of adult patients with long-term supraphysiologic glucocorticoid therapy and for supplementation therapy in case of glucocorticoid-induced adrenal insufficiency.
The 2022 clinical practice guideline, Treatment of Hypercalcemia of Malignancy in Adults, focuses on the treatment of adults with hypercalcemia of malignancy, and emphasizes controlling hypercalcemia and preventing its recurrence.
Hypoglycemia is associated with distress in those with diabetes and their families, medication nonadherence, and disruption of life and work, and it leads to costly emergency department visits and hospitalizations, morbidity, and mortality.
We are pleased to announce the release of our latest clinical practice guideline: Management of Hyperglycemia in Hospitalized Adult Patients in Non-Critical Care Settings! This new guideline reflects evolving clinical science and provides evidence-based recommendations for clinical care and practice managing hyperglycemia in the inpatient setting.
The Lipid Management in Patients with Endocrine Disorders provides an approach to assessing and treating high cholesterol in patients with endocrine diseases such as hypothyroidism, menopause, and Cushing syndrome.
A Clinical Practice Guideline update has been released, which recommend romosozumab under selective criteria as another pharmacological therapy to improve osteoporosis and reduce fracture risk in postmenopausal women.
Learn how to treat older patients with diabetes and macro and microvascular co-morbidities with the Endocrine Society clinical practice guideline, Treatment of Diabetes in Older Adults.
The Congenital Adrenal Hyperplasia Guideline reflects advances in diagnosis and treatments for congenital adrenal hyperplasia in adults, including pregnant women.
Provides recommendations for the diagnosis and treatment of hypothalamic-pituitary abnormalities and management of impaired growth in childhood cancer survivors
Recommends making a diagnosis of hypogonadism only in men with symptoms and signs consistent with testosterone (T) deficiency and unequivocally and consistently low serum T concentrations.
Functional hypothalamic amenorrhea is a diagnosis of exclusion. Use the Endocrine Society’s clinical practice guideline and related resources to decide what tests to order and what conditions to rule out to help the women with this condition.
As pediatric obesity becomes an increasing public health issue, the Endocrine Society is dedicated to providing the latest recommendations on diagnosis and treatment of pediatric obesity with updated clinical practice guidelines and related resources.
Treating hypopituitarism can be very complicated, read the latest recommendations and related resources from the Endocrine Society’s clinical practice guideline, Hormone Replacement in Hypopituitarism.
The management of obesity often involves addressing comorbid conditions and the drugs used to treat those conditions. Read the latest evidence-based recommendations from the Endocrine Society’s Pharmacological Management of Obesity clinical practice guideline and check out related resources.
The Endocrine Society recommends that acutely ill patients who have unexplained symptoms undergo diagnostic testing to rule out primary adrenal insufficiency. Find out more by reading the recommendations and related resources from our clinical practice guideline, Diagnosis and Treatment of Primary Adrenal Insufficiency.
Learn about the first line treatments for endogenous Cushing’s syndrome and explore resources related to the Endocrine Society’s clinical practice guideline, Treatment of Cushing’s Syndrome.
Using an evidence-based approach, this acromegaly guideline addresses important clinical issues regarding the evaluation and management of acromegaly, including the appropriate biochemical assessment, a therapeutic algorithm, including use of medical monotherapy or combination therapy, and management during pregnancy
We continue to recommend against making a diagnosis of androgen deficiency syndrome in healthy women because there is a lack of a well-defined syndrome, and data correlating androgen levels with specific signs or symptoms are unavailable.
The aim was to update The Endocrine Society Clinical Practice Guideline on Evaluation and Treatment of Adult Growth Hormone Deficiency (GHD) previously published in 2006.
Learn about the first line treatments for endogenous Cushing’s syndrome and explore resources related to the Endocrine Society’s clinical practice guideline, Treatment of Cushing’s Syndrome.
